Revive Therapeutics Statistics

Total Valuation

Revive Therapeutics has a market cap or net worth of CAD 4.19 million. The enterprise value is 3.44 million.

Market Cap	4.19M
Enterprise Value	3.44M

Important Dates

The last earnings date was Friday, October 25, 2024.

Earnings Date	Oct 25, 2024
Ex-Dividend Date	n/a

Share Statistics

Revive Therapeutics has 418.56 million shares outstanding. The number of shares has increased by 12.11% in one year.

Current Share Class	n/a
Shares Outstanding	418.56M
Shares Change (YoY)	+12.11%
Shares Change (QoQ)	+7.69%
Owned by Insiders (%)	1.66%
Owned by Institutions (%)	0.01%
Float	411.61M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	0.58
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-0.61
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.34, with a Debt / Equity ratio of 0.00.

Current Ratio	0.34
Quick Ratio	0.24
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-163.68

Financial Efficiency

Return on equity (ROE) is -62.83% and return on invested capital (ROIC) is -22.68%.

Return on Equity (ROE)	-62.83%
Return on Assets (ROA)	-16.52%
Return on Capital (ROIC)	-22.68%
Revenue Per Employee	n/a
Profits Per Employee	-2.81M
Employee Count	2
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -50.00% in the last 52 weeks. The beta is -0.25, so Revive Therapeutics's price volatility has been lower than the market average.

Beta (5Y)	-0.25
52-Week Price Change	-50.00%
50-Day Moving Average	0.01
200-Day Moving Average	0.02
Relative Strength Index (RSI)	52.12
Average Volume (20 Days)	286,722

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-3.29M
Pretax Income	-5.62M
Net Income	-5.62M
EBITDA	-3.29M
EBIT	-3.29M
Earnings Per Share (EPS)	-0.01

Full Income Statement

Balance Sheet

The company has 773,066 in cash and 25,216 in debt, giving a net cash position of 747,850 or 0.00 per share.

Cash & Cash Equivalents	773,066
Total Debt	25,216
Net Cash	747,850
Net Cash Per Share	0.00
Equity (Book Value)	7.23M
Book Value Per Share	0.02
Working Capital	-2.18M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-3.29M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Revive Therapeutics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-12.11%
Shareholder Yield	-12.11%
Earnings Yield	-147.67%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a